| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 25.05.
| Baxter Int'l (BAX) says low-glucose PD regimen has favorable impact on ESRD patients w/ diabetes | | - | StreetInsider.com |
| 25.05.
| Baxter Reveals Results From Combined IMPENDIA/EDEN Trials | | 40 | AFX News |
| DEERFIELD (dpa-AFX) - Baxter International Inc. (BAX) said results from two
large, international multicenter trials demonstrated that a low glucose
peritoneal dialysis, or PD, regimen favorably...
Mehr lesen zu:
Baxter Reveals Results From Combined IMPENDIA/EDEN Trials | |
| 25.05.
| Baxter's Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing Dialysis | | 46 | Business Wire |
| Treatment Regimen May Reduce Cardiovascular Risk Factors in Diabetic
Renal Patients
Baxter International Inc. (NYSE: BAX) today announced results from...
Mehr lesen zu:
Baxter's Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing Dialysis | |
| 23.05.
| Baxter to Present at Goldman Sachs 33rd Annual Global Healthcare Conference | | 37 | Business Wire |
| Baxter International Inc. (NYSE: BAX) announced today that it will
present at the Goldman Sachs 33rd Annual Global Healthcare
Conference on Wednesday, June 6, 2012, at...
Mehr lesen zu:
Baxter to Present at Goldman Sachs 33rd Annual Global Healthcare Conference | |
| 22.05.
| Possible Bullish Inside Day Candle Pattern Detected for Baxter International | | - | SmarTrend |
| 17.05.
| Baxter gains approval for ADVATE in China | | 1 | Pharma Bus Review |
| 17.05.
| Baxter baut in Transdanubien | | 4 | Wiener Zeitung |
| 16.05.
| Baxter baut in Wien um 30 Mio. Euro | | 2 | oe24.at |
| 16.05.
| Pharmakonzern Baxter investiert 30 Mio. Euro in Wien | | 5 | Die Presse |
| 16.05.
| Weitere Baxter-Investition: Grundsteinlegung für neues Produktionsgebäude | |
6 | pressetext |
| 16.05.
| Baxter's Hemophilia Drug Wins China Approval | | 32 | AFX News |
| DEERFIELD (dpa-AFX) - Baxter International Inc. (BAX) on Wednesday said
China's State Food and Drug Administration or SFDA has approved ADVATE
(Recombinant Human Coagulation Factor VIII...
Mehr lesen zu:
Baxter's Hemophilia Drug Wins China Approval | |
| 16.05.
| Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A | | 10 | Business Wire |
| ADVATE Now Approved in More than 50 Countries
Baxter International Inc. (NYSE:BAX) today announced the approval of
ADVATE
[Recombinant Human...
Mehr lesen zu:
Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A | |
| 15.05.
| Baxter Still Defensive, But Is Now The Time For Offense? | | 1 | Seeking Alpha |
| 14.05.
| Baxter Remains Neutral | | 2 | Zacks |
| 07.05.
| Baxter Declares Quarterly Dividend | | 15 | Business Wire |
| The Board of Directors of Baxter International Inc. (NYSE:BAX) today
declared a quarterly dividend of $0.335 per Baxter common share.
The dividend is payable...
Mehr lesen zu:
Baxter Declares Quarterly Dividend | |
| 04.05.
| Bearish Moving Average Cross by Baxter International | | 1 | SmarTrend |
| 02.05.
| Baxter to Present at Bank of America Merrill Lynch 2012 Healthcare Conference | | 35 | Business Wire |
| Baxter International Inc. (NYSE: BAX) announced today that it will
present at the Bank of America Merrill Lynch 2012 Healthcare Conference
on Wednesday, May 16, 2012,...
Mehr lesen zu:
Baxter to Present at Bank of America Merrill Lynch 2012 Healthcare Conference | |
| 30.04.
| Baxter reports positive Phase III data of Gammagard Liquid | | 4 | Pharma Bus Review |
| 27.04.
| Baxter Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at AAN Annual Meeting | | 26 | Business Wire |
| Baxter International Inc. (NYSE:BAX) today announced the presentation of
Phase III clinical data evaluating the safety and efficacy of GAMMAGARD
LIQUID 10% [Immune Globulin...
Mehr lesen zu:
Baxter Presents Efficacy and Safety Data Evaluating GAMMAGARD LIQUID for Multifocal Motor Neuropathy at AAN Annual Meeting | |
| 26.04.
| Baxter International Crosses Below its 10-day MA | | - | SmarTrend |
